AEK-8223415-2/11/1

Novartis Pharmaceuticals Corporation — FEI 2210396

Refusal Details

Date
March 4, 2025
Country
United States
Product Category
Drugs and Biologics
Product Code
58MCP25 SECUKINUMAB
Charges
75